LeMaitre Sign on the Building
Play Video

Press Release

LeMaitre Regains Five CE Marks

May 25, 2021 at 1:46 PM EDT

BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical Devices Directive (93/42/EC as amended by 2007/47/EC) for the following five products. Marks for the five products had previously lapsed due to a change in notified bodies.

Product Notified Body Expiration Date
XenoSure Biologic Patches TUV SUD May 26, 2024
AlboGraft Polyester Vascular Grafts TUV SUD May 26, 2024
Pruitt Carotid Shunts SGS May 24, 2024
Flexcel Carotid Shunts SGS May 24, 2024
AnastoClip Closure Systems SGS May 24, 2024

The indications for use under the new CE mark for XenoSure no longer include neuro or cardiac applications, indications for which the product was approved under its prior CE mark. Additionally, only XenoSure made from bovine pericardium sourced from certain of our suppliers is permitted to be sold under the new CE mark.

Andrew Hodgkinson, SVP of Clinical, Regulatory & Quality Affairs, said, “While our customers have largely enjoyed uninterrupted supply of most of these devices due to inventory stockpiles and local derogations, we are pleased to have received these five CE marks before the transition to the new Medical Device Regulation in the EU on May 26, 2021. We emerge from this transition having lost CE marks on several smaller product lines totaling just 3% of our 2019 EMEA sales.”

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc. This press release may include other trademarks and trade names of the Company.

For more information about the Company, please visit http://www.lemaitre.com.


Contact:
Sandra MillarLeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com

Primary Logo

Source: LeMaitre Vascular, Inc.